These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4130225)

  • 1. [Atheroid and anginin in diabetic retinopathy].
    Margolis MG; Zefirova GS; Shul'pina NB
    Vestn Oftalmol; 1973; 1():38-41. PubMed ID: 4130225
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pyridinolcarbamate (anginin) in the treatment of diabetic angiopathies].
    Tirkina TN; Aleksandrova LM; Kliachko VR; Mazovetskiĭ AG
    Ter Arkh; 1974; 46(1):107-10. PubMed ID: 4453966
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of prodectin and lipoic acid on the lipid metabolism indicators in chronic ischemic heart disease].
    Grigor'ian VA; Klantsa NA; Prishliak VD; Klantsa PN
    Vrach Delo; 1981 Oct; (10):13-5. PubMed ID: 6795820
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term treatment of diabetic retinopathy with Heparoid sublingual tablets].
    Hulej M
    Cesk Oftalmol; 1972 Mar; 28(2):116-9. PubMed ID: 4110947
    [No Abstract]   [Full Text] [Related]  

  • 5. [Value of pyridinol carbamate in ocular vascular pathology (Angioxine)].
    Boudet ; Millet ; Arnaud
    Bull Soc Ophtalmol Fr; 1974; 74(9-10):977-80. PubMed ID: 4470033
    [No Abstract]   [Full Text] [Related]  

  • 6. [Contribution of angioxine to the vascular protection of the diabetic].
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():319-27. PubMed ID: 796526
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical efficacy of eiconol in patients with diabetic retinopathy].
    Sorokin EL; Smoliakova GP; Bachaldin IL
    Vestn Oftalmol; 1997; 113(4):37-9. PubMed ID: 9381643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of pyridinolcarbamate in the treatment of diabetic angiopathies and atheromatous arteritis].
    Plauchu M; Bussy L; Rondelet J
    Lyon Med; 1972 Feb; 227(3):271-7. PubMed ID: 5037162
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of hypolipemic effect of atheroid in ischemic heart disease associated with various types of hyperlipoproteinemia].
    Zakharov VN
    Sov Med; 1978 Jan; (1):147-8. PubMed ID: 76342
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experiences with pyridinolcarbamate in ophthalmology].
    Musini A; Fabbri G; Tancini G
    Ann Ottalmol Clin Ocul; 1969 Feb; 95(2):101-23. PubMed ID: 5398786
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anginin in the treatment of coronary artery disease].
    Markiewicz M; Korolko A; Jaroszyński G
    Pol Tyg Lek; 1973 Jun; 28(23):871-3. PubMed ID: 4720261
    [No Abstract]   [Full Text] [Related]  

  • 12. [Heparinoids in the treatment of dyslipemia in patients with diabetic vasculopathy: action of 3gs].
    Cavazzini MG
    Clin Ter; 1978 Jan; 84(1):41-64. PubMed ID: 75777
    [No Abstract]   [Full Text] [Related]  

  • 13. [Protective effect of carbamate pyridinol on experimental atheroma in the rat].
    Bouissou H; Julian M; Pieraggi MT
    Pathol Biol (Paris); 1974 Oct; 22(8):713-20. PubMed ID: 4614172
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes of the electrophoretic tracing of the serum glycoproteins in diabetic subjects treated with pyridinolcarbamate].
    Notarbartolo A; Rini GB; Di Fede G
    Boll Soc Ital Cardiol; 1973; 18(4):379-83. PubMed ID: 4807078
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influence of pyridinolcarbamate on platelet aggregation in diabetic subjects with ischemic cardiopathy].
    Citarrella P; Abbadessa V; Pecorella M; Cajozzo A
    Boll Soc Ital Cardiol; 1977; 22(7):1036-41. PubMed ID: 618239
    [No Abstract]   [Full Text] [Related]  

  • 16. [The pyridinolcarbamate-clofibrate combination in the treatment of vascular diseases in diabetics].
    Parodi FA; Caputo G
    Clin Ter; 1976 Dec; 79(6):571-81. PubMed ID: 1009761
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of the effectiveness of anginine treatment of diabetic microangiopathies].
    Spesivtseva VG; Frenkel' VKh; Mamaeva GG; Sokolovskiĭ GA; Kukes VG
    Sov Med; 1975 Jul; (7):42-5. PubMed ID: 1216049
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pyridinolcarbamate in the treatment of peripheral vascular diseases in diabetics. Observations after 3 years of clinical use].
    Parodi FA
    Minerva Med; 1974 May; 65(40):2316-20. PubMed ID: 4421119
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic efficacy of pyridinolcarbamate (Anginin) in patients with combined cerebral and peripheral arteriosclerosis].
    Majkowski J; Lysakowska-Sernicka K; Gajewska A; Bilińska-Nigot B; Ostrowski K; Semenicki K
    Neurol Neurochir Pol; 1978; 12(4):387-96. PubMed ID: 714218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the effectiveness of anginin and stugeron treatment of cerebral arteriosclerosis].
    Sobczyk W; Kruszewska J; Szymchel J
    Neurol Neurochir Pol; 1980; 14(2):183-9. PubMed ID: 6993976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.